Literature DB >> 9080475

Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand.

J Noguchi1, K Ishiwata, R Furuta, J Simada, M Kiyosawa, S Ishii, K Endo, F Suzuki, M Senda.   

Abstract

We prepared [11C]KF15372 ([1-propyl-11C]8-dicyclopropylmethyl-1,3-dipropylxanthine, refs 10, 13) as well as its 11C-ethyl and 11C-methyl derivatives ([11C]EPDX and [11C]MPDX), and examined the potential of the three compounds as PET ligands for CNS adenosine A1 receptors. The three compounds had high affinity for the A1 receptors in vitro in the following order; [11C]EPDX > [11C]KF15372 > [11C]MPDX. In mice, the highest initial brain uptake was found in [11C]MPDX followed by [11C]EPDX and [11C]KF15372, but the level of [11C]MPDX decreased faster than those of the other two compounds. The uptake of each compound was decreased by carrier KF15372, but not by an A2A antagonist, indicating the selective affinity for the A1 receptors. Autoradiography with [11C]MPDX ex vivo demonstrated decreased A1 receptor binding in the superior colliculus of rats deprived of retino-collicular fibers by contralateral eye enucleation. These results show that three compounds have potential as PET ligands for CNS adenosine A1 receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080475     DOI: 10.1016/s0969-8051(96)00161-8

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

2.  Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

Authors:  David Elmenhorst; Philipp T Meyer; Andreas Matusch; Oliver H Winz; Karl Zilles; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-23       Impact factor: 9.236

Review 3.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

4.  Discovery of Highly Potent Adenosine A1 Receptor Agonists: Targeting Positron Emission Tomography Probes.

Authors:  Min Guo; Abolghasem Bakhoda; Zhan-Guo Gao; Joseph M Ramsey; Yang Li; Kelly A O'Conor; Andrew C Kelleher; Seth M Eisenberg; Yeona Kang; Xuefeng Yan; Cameron Javdan; Joanna S Fowler; Kenner C Rice; Jacob M Hooker; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  ACS Chem Neurosci       Date:  2021-09-01       Impact factor: 5.780

5.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

6.  Age-Related Decrease in Male Extra-Striatal Adenosine A1 Receptors Measured Using11C-MPDX PET.

Authors:  Masahiro Mishina; Yuichi Kimura; Muneyuki Sakata; Kenji Ishii; Keiichi Oda; Jun Toyohara; Kazumi Kimura; Kiichi Ishiwata
Journal:  Front Pharmacol       Date:  2017-12-18       Impact factor: 5.810

Review 7.  Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications.

Authors:  Hamideh Zarrinmayeh; Paul R Territo
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.